VivaVision Biotech

company

About

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company.

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
¥65M
Industries
Biotechnology
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥365M
VivaVision Biotech has raised a total of ¥365M in funding over 2 rounds. Their latest funding was raised on Apr 21, 2021 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 21, 2021 Series D ¥300M 4 Detail
Sep 26, 2019 Series C ¥65M 3 Detail

Investors

Number of Lead Investors
Number of Investors
6
VivaVision Biotech is funded by 6 investors. CFS Capital and FengHe Fund Management are the most recent investors.
Investor Name Lead Investor Funding Round
CFS Capital Series D
FengHe Fund Management Series D
Cenova Capital Series D
Beida Biomedical Industry Fund Series D
Donghan International Series C
Yingqi Investment Series C